EDTA (Ethylenediaminetetraacetic acid) is a water-soluble compound that belongs to a class of molecules called chelators (from the Greek word chelé, meaning “claw”) that bind(chelate), metals and remove them from the body. This may help detox excess graphene oxide.
EDTA was first used in the 1950s for the treatment of heavy metal poisoning. Calcium disodium EDTA chelation removes heavy metals and is approved by the FDA for use in treating lead poisoning and toxicity from other heavy metals. Intravenous EDTA is used to treat lead poisoning and brain damage caused by lead poisoning; to see how well therapy for suspected lead poisoning is working; to treat poisonings by radioactive materials such as plutonium, thorium, uranium, and strontium.
EDTA is also used intravenously for heart and blood vessel conditions including irregular heartbeat due to exposure to chemicals called cardiac glycosides, "hardening of the arteries"(atherosclerosis), chest pain(angina), high blood pressure, high cholesterol, stroke, and blood circulation problems. Other intravenous uses include treatment of cancer, rheumatoid arthritis, osteoarthritis, an eye condition called macular degeneration, diabetes, Alzheimer's disease, multiple sclerosis, Parkinson's disease, and skin conditions including scleroderma and psoriasis.
